Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update Pharmaceutical Investing
Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today's Modern Aesthetics Practices Pharmaceutical Investing
Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference Pharmaceutical Investing
Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas Life Science Investing
Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm Sublingual Film Pharmaceutical Investing
Minerva Neurosciences Provides Second Quarter 2026 Financial Results and Business Updates Pharmaceutical Investing
CytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update Life Science Investing
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results Life Science Investing
Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress Pharmaceutical Investing
